Dimmeler, Stefanie
Ding, Sheng
Rando, Thomas A
Trounson, Alan
Article History
Received: 5 June 2014
Accepted: 5 June 2014
First Online: 6 August 2014
Competing interests
: S. Dimmeler is founder of and adviser to t2Cure GmbH and adviser to miRagen Therapeutics. The other authors declare no conflict of interest.